Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Yen Lin

Showing results (151-160 of 233) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2013
Altered T-bet dominance in IFN-γ-decoupled CD4+ T cells with attenuated cytokine storm and preserved memory in influenzaAvijit Dutta, Shi-Chuen Miaw, Jhang-Sian Yu, et al.
American Journal of Cancer Research|December 7, 2023
A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefitChung-Wei Su, Wei Teng, Po-Ting Lin, et al.
Journal of Cancer|June 22, 2026
<i>GALNT14</i>-rs9679162 Genotypes Predict Post-immunotherapy Side Effect and Survival in Patients with Hepatitis B Virus-related Hepatocellular CarcinomaPo-Ting Lin, Wei Teng, Wei-Ting Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumabI-Wen Chen, Cheng-Wei Lin, Po-Ting Lin, et al.
American Journal of Cancer Research|November 12, 2021
Complete response at first transarterial chemoembolization predicts favorable outcome in hepatocellular carcinomaChien-Wei Peng, Wei Teng, Kar-Wai Lui, et al.
Journal for Immunotherapy of Cancer|June 22, 2022
The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancerJung-Tung Hung, I-Ju Chen, Shir-Hwa Ueng, et al.
Cancers|October 16, 2025
Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus BevacizumabTai-Chi Wu, Po-Ting Lin, Wei Teng, et al.
Scientific Reports|May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysisChun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
Journal of Gastroenterology and Hepatology|March 14, 2015
Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomasYu-Hung Su, Kwai-Fong Ng, Ming-Chin Yu, et al.
Dalton Transactions (Cambridge, England : 2003)|March 14, 2014
Electrochemical synthesis, characterization of Ir-Zn containing coordination polymer, and application in oxygen and glucose sensingKum-Yi Cheng, Jing-Chang Wang, Chun-Yen Lin, et al.
Pageof 24

Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2013
Altered T-bet dominance in IFN-γ-decoupled CD4+ T cells with attenuated cytokine storm and preserved memory in influenzaAvijit Dutta, Shi-Chuen Miaw, Jhang-Sian Yu, et al.
American Journal of Cancer Research|December 7, 2023
A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefitChung-Wei Su, Wei Teng, Po-Ting Lin, et al.
Journal of Cancer|June 22, 2026
<i>GALNT14</i>-rs9679162 Genotypes Predict Post-immunotherapy Side Effect and Survival in Patients with Hepatitis B Virus-related Hepatocellular CarcinomaPo-Ting Lin, Wei Teng, Wei-Ting Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumabI-Wen Chen, Cheng-Wei Lin, Po-Ting Lin, et al.
American Journal of Cancer Research|November 12, 2021
Complete response at first transarterial chemoembolization predicts favorable outcome in hepatocellular carcinomaChien-Wei Peng, Wei Teng, Kar-Wai Lui, et al.
Journal for Immunotherapy of Cancer|June 22, 2022
The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancerJung-Tung Hung, I-Ju Chen, Shir-Hwa Ueng, et al.
Cancers|October 16, 2025
Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus BevacizumabTai-Chi Wu, Po-Ting Lin, Wei Teng, et al.
Scientific Reports|May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysisChun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
Journal of Gastroenterology and Hepatology|March 14, 2015
Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomasYu-Hung Su, Kwai-Fong Ng, Ming-Chin Yu, et al.
Dalton Transactions (Cambridge, England : 2003)|March 14, 2014
Electrochemical synthesis, characterization of Ir-Zn containing coordination polymer, and application in oxygen and glucose sensingKum-Yi Cheng, Jing-Chang Wang, Chun-Yen Lin, et al.
Pageof 24